Pelican Appoints New CEO
Protective case manufacturer hires James Curleigh, as company prepares to further innovation and expand.
Pelican Products, Inc., a manufacturer of protective cases that specializes intemperature-controlled packaging via its Peli BioThermal division, has appointed James “JC” Curleigh as the company’s new CEO. He has over 30 years of experience in brands such as M&M Mars, Salomon Sports, TaylorMade Golf, Keen Footwear, Levi’s Apparel and most recently Gibson Guitars.
Curleigh’s expertise will play a pivotal role in advancing Pelican’s mission, leading the strategic direction, focusing on product innovation, driving customer engagement, and accelerating market expansion. In his new role, Curleigh aims to leverage emerging technologies and trends to keep Pelican moving in the right direction.
“JC brings deep consumer and commercial experience to Pelican, a brand that has built tremendous loyalty and is now ready for the next stage of growth,” says Brandon Crawley, interim CEO of Pelican and managing director at Platinum Equity, which acquired Pelican in 2021. “Pelican’s well-deserved reputation in protective cases lays the groundwork for development of a more diverse product set. JC is the right leader to continue to broaden Pelican’s reach and leverage its core strengths to capitalize on emerging opportunities in the industry.”
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.
